Back
Axsome Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
44
AXSM
Axsome Therapeutics
Last Price:
95.22
Seasonality Move:
24.95%
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
125.86
Seasonality Move:
0.19%
Sell
44
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
- The current Axsome Therapeutics [AXSM] share price is $94.43. The Score for AXSM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $127.10. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $94.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $127.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.7 | Buy |
| Relative Strength Index (14 RSI): | 61.42 | Buy |
| Chaikin Money Flow: | 89031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.76 - 93.16) | Buy |
| Bollinger Bands (100): | (75.31 - 88.45) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.72 | Sell |
| Relative Strength Index (14 RSI): | 38.7 | Sell |
| Chaikin Money Flow: | -11607 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (127.06 - 139.4) | Sell |
| Bollinger Bands (100): | (124.44 - 147.62) | Sell |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.3 | Buy |
| 20-day SMA: | 91.17 | Buy |
| 50-day SMA: | 87.58 | Buy |
| 200-day SMA: | 80.64 | Buy |
| 8-day EMA: | 92.46 | Buy |
| 20-day EMA: | 91.11 | Buy |
| 50-day EMA: | 87.67 | Buy |
| 200-day EMA: | 80.32 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.94 | Buy |
| 20-day SMA: | 132.14 | Sell |
| 50-day SMA: | 138.1 | Sell |
| 200-day SMA: | 126.4 | Buy |
| 8-day EMA: | 126.81 | Buy |
| 20-day EMA: | 130.43 | Sell |
| 50-day EMA: | 134.6 | Sell |
| 200-day EMA: | 128.85 | Sell |
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.99 per share, a decrease this year of $1.26 per share, and an increase next year of $3.97 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Axsome Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||